June 29, 2026 · Form 4 insider transaction
Patel Sushil bought 2,955 shares of Revolution Medicines, Inc. at $37.54 per share, a transaction worth $110.9K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Transaction made pursuant to a 10b5-1 trading plan adopted by Sushil Patel on March 30, 2026.; Includes 1,191 restricted stock units.